Developing science, technology and innovation indicators: What we can learn from the past

DIPG in Children – What Can We Learn from the Past?

Brainstem tumors represent 10-15% of pediatric central nervous system tumors and diffuse intrinsic pontine glioma (DIPG) is the most common brainstem tumor of childhood. DIPG is almost uniformly fatal and is the leading cause of brain tumor-related death in children. To date, radiation therapy (RT) is the only form of treatment that offers a transient benefit in DIPG. Chemotherapeutic strategie...

What Can We Learn from 21 Years of School Poisonings in New Zealand?

Background: Childhood poisoning is a significant international health concern. Very little is known about trends in exposures within schools and preschools. The objectives of this study were to investigate the data recorded by the New Zealand National Poisons Centre (NPC) on these types of exposures over a 21 year period (1989 to 2009) and to determine trends and propose strategies to reduce th...

What Businesses Can Learn from Financial Innovation

What we can learn from atmospheric neutrinos

Physics potential of future measurements of atmospheric neutrinos is explored. Observation of ∆m221 driven sub-dominant effects and θ13 driven large matter effects in atmospheric neutrinos can be used to study the deviation of θ23 from maximality and its octant. Neutrino mass hierarchy can be determined extremely well due to the large matter effects. New physics can be constrained both in stand...

What can we learn from Europe?

The European Society of Cardiology has produced guidelines for the treatment of acute myocardial infarction as well as for chronic heart failure and for the use of beta blockers and angiotensin converting enzyme inhibitors. These documents provide clear evidence and strength of recommendations for the secondary prevention of complications after a myocardial infarction. The identification of hea...